Clinical trial
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
NCT05215327 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- November 8, 2022
- Completion date
- December 31, 2027
- Enrollment
- 270 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immunization; infection, influenza, transplantation infection